[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Hims & Hers Health Inc (HIMS)

Hims & Hers Health Inc (HIMS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Market News and Commentary

Hims & Hers' AI-First Weight Loss Bet Faces Its First Earnings Test

Hims & Hers Health Inc (HIMS) reports Q2 2026 earnings after market close on August 10, 2026, with analysts expecting a loss of $0.07 per share—a sharp reversal from the $0.17 profit posted in the same quarter last year. The report comes at a critical juncture for the telehealth platform, following a disastrous Q1 miss that saw the company report a $0.18 loss versus a $0.04 profit estimate, triggering a 550% negative surprise and raising questions about the sustainability of its growth trajectory.

Hims & Hers Health operates a direct-to-consumer telehealth platform offering personalized treatments across categories including sexual health, hair loss, dermatology, mental health, and weight management....

Fundamentals

See More
  • Market Capitalization, $K 7,311,758
  • Shares Outstanding, K 231,458
  • Annual Sales, $ 2,348 M
  • Annual Income, $ 128,370 K
  • EBIT $ -31 M
  • EBITDA $ 26 M
  • 60-Month Beta 2.40
  • Price/Sales 2.92
  • Price/Cash Flow 35.44
  • Price/Book 15.34

Options Overview Details

View History
  • Implied Volatility 91.91% (-5.59%)
  • Historical Volatility 98.41%
  • IV Percentile 57%
  • IV Rank 47.96%
  • IV High 127.22% on 10/16/25
  • IV Low 59.38% on 12/31/25
  • Expected Move (DTE 4) 3.89 (12.32%)
  • Put/Call Vol Ratio 0.52
  • Today's Volume 88,197
  • Volume Avg (30-Day) 89,864
  • Put/Call OI Ratio 0.64
  • Today's Open Interest 909,995
  • Open Int (30-Day) 921,712
  • Expected Range 27.70 to 35.48

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 15 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $-0.07
  • Number of Estimates 3
  • High Estimate $-0.01
  • Low Estimate $-0.16
  • Prior Year $0.17
  • Growth Rate Est. (year over year) -141.18%

Price Performance

See More
Period Period Low Period High Performance
1-Month
24.24 +30.32%
on 07/30/26
37.70 -16.21%
on 07/16/26
-4.58 (-12.66%)
since 07/07/26
3-Month
21.53 +46.73%
on 05/19/26
39.05 -19.10%
on 07/06/26
+5.94 (+23.16%)
since 05/07/26
52-Week
13.74 +129.91%
on 02/24/26
65.30 -51.62%
on 10/15/25
-19.46 (-38.12%)
since 08/07/25

Most Recent Stories

More News
Hims & Hers Health Earnings: What To Look For From HIMS

Hims & Hers Health Earnings: What To Look For From HIMS

HIMS : 31.59 (+6.51%)
HIMS Investigation Notice: Kessler Topaz Meltzer & Check, LLP Encourages Hims & Hers Health, Inc. (NYSE: HIMS) Investors to Contact the Firm

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

HIMS : 31.59 (+6.51%)
HIMS Investigation: Kessler Topaz Meltzer & Check, LLP Encourages Hims & Hers Health, Inc. (NYSE: HIMS) Investors to Contact the Firm

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

HIMS : 31.59 (+6.51%)
Hims & Hers' AI-First Weight Loss Bet Faces Its First Earnings Test

Barchart Research What to Expect from HIMS Earnings HIMS Generated August 7, 2026 Current Price $31.59 EPS Estimate $$-0.07 Consensus Rating Hold Average Move 9.60% Hims & Hers' AI-First Weight Loss Bet...

HIMS : 31.59 (+6.51%)
HIMS Investigation Alert: Kessler Topaz Meltzer & Check, LLP Encourages Hims & Hers Health, Inc. (NYSE: HIMS) Investors to Contact the Firm

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

HIMS : 31.59 (+6.51%)
1 Healthcare Stock Worth Your Attention and 2 We Ignore

1 Healthcare Stock Worth Your Attention and 2 We Ignore

ACHC : 31.53 (+2.64%)
HIMS : 31.59 (+6.51%)
AMRX : 18.14 (+0.39%)
NYSE: HIMS Investigation Reminder: Kessler Topaz Meltzer & Check, LLP Encourages Hims & Hers Health, Inc. (NYSE: HIMS) Investors to Contact the Firm

RADNOR, PA - August 6, 2026 (NEWMEDIAWIRE) - Kessler Topaz Meltzer & Check, LLP (www.ktmc.com), a nationally recognized securities litigation law firm, is investigating potential violations of the federal...

HIMS : 31.59 (+6.51%)
Kaplan Fox Reminds Investors of Hims & Hers Health, Inc. (NYSE: HIMS) of an Ongoing Investigation Into Potential Securities Law Violations

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

BAC : 63.17 (+0.27%)
HIMS : 31.59 (+6.51%)
Hims & Hers Introduces New Hers App with First-of-Its-Kind, Doctor-Led, AI-Native Care Experience

Rebuilt from the ground up, the new Hers app puts women in one continuous conversation with their providers, Care Teams, and AI, delivering personalized weight loss support the moment she needs it

HIMS : 31.59 (+6.51%)
NYSE: HIMS Investigation Reminder: Kessler Topaz Meltzer & Check, LLP Encourages Hims & Hers Health, Inc. (NYSE: HIMS) Investors to Contact the Firm

RADNOR, Pa. , Aug. 5, 2026 /PRNewswire/ -- Kessler Topaz Meltzer & Check, LLP ( www.ktmc.com ), a nationally recognized securities litigation law firm, is investigating potential violations of...

HIMS : 31.59 (+6.51%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Weakening short term outlook on maintaining the current direction.

Relative Strength just crossed above 50%. The market is indicating support for a bullish trend.

See More Share

Business Summary

Hims & Hers Health Inc. is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling medical care for numerous conditions related to mental health, sexual health, dermatology, primary care and more. Hims & Hers Health Inc., formerly known as Oaktree...

See More

Key Turning Points

3rd Resistance Point 34.19
2nd Resistance Point 32.96
1st Resistance Point 32.27
Last Price 31.59
1st Support Level 30.35
2nd Support Level 29.12
3rd Support Level 28.43

See More

52-Week High 65.30
Fibonacci 61.8% 45.60
Fibonacci 50% 39.52
Fibonacci 38.2% 33.44
Last Price 31.59
52-Week Low 13.74

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.